Structures by: Khan I. U.
Total: 250
<i>N</i>'-(phenylsulfonyl)carbamimidic azide
C7H7N5O2S
Acta Crystallographica Section E (2011) 67, 10 o2703
a=7.0399(2)Å b=7.1714(2)Å c=10.3670(3)Å
α=90.2670(10)° β=98.9970(10)° γ=110.3580(10)°
6-Bromo-4-(2-cyclohexylidenehydrazin-1-ylidene)-1-methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine
C15H18BrN3O2S
Acta Crystallographica Section E (2012) 68, 7 o2088-o2089
a=9.9357(2)Å b=11.2614(3)Å c=15.8263(3)Å
α=110.6250(10)° β=91.525(3)° γ=102.879(4)°
1-Methyl-4-[1-(1-phenylethylidene)-hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>- 2λ^6^,1-benzothiazine-2,2-dione
C17H17N3O2S
Acta Crystallographica Section E (2012) 68, 7 o2100
a=6.6678(2)Å b=12.0783(6)Å c=20.0529(8)Å
α=90.00° β=90.00° γ=90.00°
2-{(<i>E</i>)-[(2<i>Z</i>)-(3-Chloro-1-methyl-2,2-dioxo-3,4-dihydro- 1<i>H</i>-2,1-benzothiazin-4-ylidene)hydrazinylidene]methyl}phenol
C16H14ClN3O3S
Acta Crystallographica Section E (2012) 68, 2 o307
a=7.0973(5)Å b=12.0957(7)Å c=18.7396(13)Å
α=90.00° β=96.058(4)° γ=90.00°
Anilinium-3-carboxylate 3-carboxyanilinium nitrate
C7H8NO2,NO3,C7H7NO2
Acta Crystallographica Section E (2013) 69, 1 o29
a=16.0451(3)Å b=4.75750(10)Å c=19.7143(4)Å
α=90.00° β=107.6600(10)° γ=90.00°
3-Chloro-1-methyl-4-[2-(3-phenylallylidene)hydrazinylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C18H16ClN3O2S
Acta Crystallographica Section E (2013) 69, 2 o165
a=7.2262(5)Å b=13.5823(9)Å c=17.9818(12)Å
α=90.00° β=97.023(4)° γ=90.00°
2-Chloro-4-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2011) 67, 6 o1327
a=14.1522(8)Å b=7.3203(4)Å c=14.7193(8)Å
α=90.00° β=104.892(2)° γ=90.00°
Methyl 4-hydroxy-2-isopropyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C13H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1823-o1824
a=11.3896(6)Å b=9.8421(5)Å c=12.7680(7)Å
α=90.00° β=105.7820(10)° γ=90.00°
4-(4-Methoxybenzenesulfonamido)benzoic acid
C14H13NO5S
Acta Crystallographica Section E (2011) 67, 7 o1857
a=8.6980(3)Å b=21.7471(8)Å c=14.5824(6)Å
α=90° β=95.153(2)° γ=90°
Methyl 2-amino-5-bromobenzoate
C8H8BrNO2
Acta Crystallographica Section E (2011) 67, 8 o1887
a=3.9852(2)Å b=9.1078(5)Å c=12.1409(7)Å
α=90° β=95.238(3)° γ=90°
6-Bromo-1-methyl-4-[2-(4-methylbenzylidene)hydrazinylidene]-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2092
a=9.1077(6)Å b=6.8328(4)Å c=14.1765(9)Å
α=90.00° β=96.807(3)° γ=90.00°
<i>N</i>-[Amino(azido)methylidene]-4-methylbenzenesulfonamide
C8H9N5O2S
Acta Crystallographica Section E (2011) 67, 8 o2140
a=6.8986(2)Å b=7.2146(2)Å c=11.3771(3)Å
α=92.2440(10)° β=93.6150(10)° γ=110.5050(10)°
4-[(4-Methoxybenzenesulfonamido)methyl]cyclohexane-1-carboxylic acid
C15H21NO5S
Acta Crystallographica Section E (2011) 67, 9 o2248-o2249
a=5.9119(3)Å b=10.7223(7)Å c=26.6453(15)Å
α=79.736(3)° β=89.813(3)° γ=75.518(3)°
<i>N</i>-(2-Bromophenyl)-4-methyl-<i>N</i>-(4-methylphenylsulfonyl)benzenesulfonamide
C20H18BrNO4S2
Acta Crystallographica Section E (2011) 67, 9 o2356
a=10.5819(15)Å b=13.1465(19)Å c=14.235(2)Å
α=90.00° β=95.478(2)° γ=90.00°
<i>N</i>-[4-(Ethylsulfamoyl)phenyl]acetamide
C10H14N2O3S
Acta Crystallographica Section E (2011) 67, 9 o2455
a=8.2766(3)Å b=12.1728(4)Å c=13.5041(4)Å
α=70.130(2)° β=73.935(2)° γ=71.517(2)°
<i>N</i>,<i>N</i>'-(Propane-1,3-diyl)bis(<i>p</i>-toluenesulfonamide)
C17H22N2O4S2
Acta Crystallographica Section E (2011) 67, 9 o2371
a=12.3169(9)Å b=18.0787(15)Å c=8.3819(5)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>)-3-(1<i>H</i>-Indol-3-yl)-2-(4-methylbenzenesulfonamido)propionic acid monohydrate
C18H18N2O4S,H2O
Acta Crystallographica Section E (2011) 67, 9 o2325
a=8.4531(10)Å b=5.2521(5)Å c=20.867(2)Å
α=90.00° β=98.056(4)° γ=90.00°
Methyl 4-hydroxy-1,1-dioxo-2-(2-phenylethyl)-2<i>H</i>-1λ^6^,2-benzothiazine-3-carboxylate
C18H17NO5S
Acta Crystallographica Section E (2011) 67, 12 o3445
a=9.018(2)Å b=19.026(4)Å c=10.193(2)Å
α=90.00° β=106.441(3)° γ=90.00°
<i>N</i>,<i>N</i>'-Diallyl-2,2',5,5'-tetrachloro-<i>N</i>,<i>N</i>'- [1,3-phenylenebis(methylene)]dibenzenesulfonamide
C26H24Cl4N2O4S2
Acta Crystallographica Section E (2011) 67, 12 o3280
a=8.2744(2)Å b=11.3398(2)Å c=15.6481(4)Å
α=87.7770(10)° β=84.4430(10)° γ=84.2570(10)°
<i>N</i>,<i>N</i>'-Bis(3-methylbut-2-enyl)-<i>N</i>,<i>N</i>'-(1,4- phenylene)dibenzenesulfonamide
C28H32N2O4S2
Acta Crystallographica Section E (2011) 67, 12 o3281
a=10.6574(4)Å b=20.8073(8)Å c=6.4015(2)Å
α=90.00° β=105.673(2)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis(3,3-dimethylallyl)-<i>N</i>,<i>N</i>'- (propane-1,3-diyl)dibenzenesulfonamide
C25H34N2O4S2
Acta Crystallographica Section E (2011) 67, 12 o3507
a=10.3019(2)Å b=16.3962(4)Å c=16.0500(4)Å
α=90.00° β=108.4490(10)° γ=90.00°
2,2',5,5'-Tetrachloro-<i>N</i>,<i>N</i>'-diethyl-<i>N</i>,<i>N</i>'- [benzene-1,3-diylbis(methylene)]dibenzenesulfonamide
C24H24Cl4N2O4S2
Acta Crystallographica Section E (2012) 68, 1 o15
a=8.0396(2)Å b=11.1512(3)Å c=15.5723(3)Å
α=87.4540(10)° β=83.3780(10)° γ=87.9950(10)°
<i>N</i>'-[(<i>Z</i>)-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methylidene]-2-hydroxybenzohydrazide
C19H18N4O3
Acta Crystallographica Section E (2012) 68, 2 o352
a=25.2357(6)Å b=8.5624(2)Å c=16.0329(4)Å
α=90.00° β=104.0480(10)° γ=90.00°
3-(Propan-2-yloxy)-1,2-benzothiazole 1,1-dioxide
C10H11NO3S
Acta Crystallographica Section E (2012) 68, 2 o507
a=8.1899(3)Å b=8.8361(4)Å c=8.9045(4)Å
α=101.624(2)° β=106.6940(10)° γ=114.8980(10)°
Bis(methacrylato-κ<i>O</i>)bis(2,4,6-trimethylpyridine-κ<i>N</i>)copper(II)
C24H32CuN2O4
Acta Crystallographica Section E (2012) 68, 4 m469-m470
a=8.2295(2)Å b=17.0921(6)Å c=9.1683(3)Å
α=90.00° β=109.2200(10)° γ=90.00°
2-{4-[Acetyl(ethyl)amino]benzenesulfonamido}benzoic acid
C17H18N2O5S
Acta Crystallographica Section E (2012) 68, 5 o1305
a=18.0371(7)Å b=12.0249(4)Å c=7.8430(2)Å
α=90° β=90° γ=90°
Methyl 5-bromo-2-hydroxybenzoate
C8H7BrO3
Acta Crystallographica Section E (2012) 68, 5 o1467
a=3.9829(8)Å b=9.0950(19)Å c=12.122(3)Å
α=90° β=95.162(9)° γ=90°
Propyl 2-(4-methylbenzenesulfonamido)benzoate
C17H19NO4S
Acta Crystallographica Section E (2012) 68, 5 o1388
a=16.206(5)Å b=8.513(2)Å c=12.021(3)Å
α=90° β=92.352(2)° γ=90°
Cyanomethyl 4-(4-methylbenzenesulfonamido)benzoate
C16H14N2O4S
Acta Crystallographica Section E (2012) 68, 5 o1488
a=5.9360(3)Å b=8.1992(4)Å c=15.9068(8)Å
α=90° β=91.222(3)° γ=90°
<i>catena</i>-Poly[[[pentaaquacerium(III)]-μ-pyridine-2,4,6-tricarboxylato- κ^4^<i>N</i>,<i>O</i>^2^,<i>O</i>^6^:<i>O</i>^6^)] tetrahydrate]
C8H12CeNO11,4(H2O)
Acta Crystallographica Section E (2012) 68, 5 m624-m625
a=6.8437(3)Å b=13.3207(5)Å c=17.9045(7)Å
α=90.00° β=90.00° γ=90.00°
Butyl 4-(4-methylbenzenesulfonamido)benzoate
C18H21NO4S
Acta Crystallographica Section E (2012) 68, 5 o1541
a=17.8216(13)Å b=8.2702(6)Å c=11.9282(8)Å
α=90° β=91.001(3)° γ=90°
1-Ethyl-4-[1-(1-phenylethylidene)hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C18H19N3O2S
Acta Crystallographica Section E (2012) 68, 6 o1927
a=9.7278(3)Å b=12.4327(3)Å c=14.2607(4)Å
α=90.00° β=100.7250(10)° γ=90.00°
Methyl 2-butyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carboxylate
C14H17NO5S
Acta Crystallographica Section E (2012) 68, 6 o1663
a=25.173(7)Å b=9.280(2)Å c=12.531(3)Å
α=90.00° β=91.741(3)° γ=90.00°
<i>rac</i>-(3<i>S</i>,4<i>Z</i>)-3-Chloro-4-[2-(3- fluorobenzylidene)hydrazinylidene]- 3-chloro-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13ClFN3O2S
Acta Crystallographica Section E (2012) 68, 6 o1787
a=7.0072(3)Å b=8.9402(4)Å c=13.3438(6)Å
α=98.184(3)° β=90.510(2)° γ=98.389(3)°
4-[2-(Anthracen-9-ylmethylidene)hydrazinylidene]-3-chloro-1-methyl- 3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C24H18ClN3O2S
Acta Crystallographica Section E (2012) 68, 6 o1788
a=8.5133(4)Å b=19.8999(8)Å c=12.7849(6)Å
α=90° β=105.026(2)° γ=90°
3-(1<i>H</i>-Indol-3-yl)-2-(2-nitrobenzenesulfonamido)propanoic acid
C17H15N3O6S
Acta Crystallographica Section E (2012) 68, 7 o2019
a=9.6818(5)Å b=9.6818(5)Å c=44.017(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2,3-Dihydro-1,4-benzodioxin-6-yl)-4-fluorobenzenesulfonamide
C14H12FNO4S
Acta Crystallographica Section E (2012) 68, 8 o2433
a=5.1542(5)Å b=22.237(3)Å c=12.0706(13)Å
α=90.00° β=94.422(3)° γ=90.00°
2-{[2-(1-Methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazin-4-ylidene)hydrazin-1-ylidene]methyl}phenol
C16H15N3O3S
Acta Crystallographica Section E (2012) 68, 9 o2643
a=6.5530(2)Å b=15.8719(5)Å c=14.5804(4)Å
α=90.00° β=91.1470(10)° γ=90.00°
2,5-Dichloro-<i>N</i>-(2,3-dimethylphenyl)benzenesulfonamide
C14H13Cl2NO2S
Acta Crystallographica Section E (2012) 68, 9 o2748
a=13.0069(11)Å b=10.0775(9)Å c=22.408(2)Å
α=90.00° β=90.00° γ=90.00°
2-(1<i>H</i>-Indol-3-yl)acetohydrazide
C10H11N3O
Acta Crystallographica Section E (2012) 68, 11 o3140-o3141
a=12.1599(7)Å b=9.6153(4)Å c=16.2345(8)Å
α=90.00° β=90.00° γ=90.00°
6-Bromo-4-[2-(4-fluorobenzylidene)hydrazin-1-ylidene]-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13BrFN3O2S
Acta Crystallographica Section E (2012) 68, 10 o2851
a=7.8996(4)Å b=9.0070(4)Å c=13.5057(7)Å
α=104.176(3)° β=90.977(3)° γ=113.466(3)°
<i>N</i>-(2,3-Dimethylphenyl)-4-fluoro-<i>N</i>-[(4-fluorophenyl)sulfonyl] benzenesulfonamide
C20H17F2NO4S2
Acta Crystallographica Section E (2012) 68, 10 o2973
a=9.9493(5)Å b=14.7107(8)Å c=26.6871(17)Å
α=90.00° β=90.00° γ=90.00°
Hexakis(μ~3~-1-methylthiourea- κ^3^<i>S</i>:<i>S</i>:<i>S</i>)hexakis[iodidocopper(I)]
C12H36Cu6I6N12S6
Acta Crystallographica Section E (2012) 68, 11 m1405-m1406
a=21.75170(10)Å b=21.75170(10)Å c=7.62690(10)Å
α=90.00° β=90.00° γ=120.00°
<i>N</i>-(2,3-Dimethylphenyl)-4-methyl-<i>N</i>-(4- methylphenylsulfonyl)benzenesulfonamide
C22H23NO4S2
Acta Crystallographica Section E (2012) 68, 10 o3013
a=7.5523(8)Å b=8.4635(9)Å c=17.5004(17)Å
α=103.282(7)° β=91.659(7)° γ=108.382(7)°
(4<i>Z</i>)-1-Methyl-4-[(2<i>E</i>)-2-(4-methylbenzylidene)hydrazin-1- ylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H17N3O2S
Acta Crystallographica Section E (2012) 68, 10 o2971
a=7.8990(10)Å b=25.061(3)Å c=8.1743(11)Å
α=90.00° β=101.114(9)° γ=90.00°
2-(Naphthalene-2-sulfonamido)-3-phenylpropanoic acid
C19H17NO4S
Acta Crystallographica Section E (2013) 69, 2 o194
a=8.0694(2)Å b=15.2168(4)Å c=14.0996(3)Å
α=90.00° β=92.505(2)° γ=90.00°
6-Bromo-1-methyl-4-[2-(1-phenylethylidene)hydrazinylidene]- 3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2013) 69, 2 o164
a=16.4369(13)Å b=6.5400(5)Å c=16.5025(17)Å
α=90.00° β=104.312(4)° γ=90.00°
3-Chloro-4-[2-(4-chlorobenzylidene)hydrazinylidene]-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13Cl2N3O2S
Acta Crystallographica Section E (2013) 69, 3 o422-o423
a=12.309(2)Å b=17.189(3)Å c=8.1837(13)Å
α=90.00° β=101.632(8)° γ=90.00°
2-Chloro-6-(2,3-dichlorobenzenesulfonamido)benzoic acid
C13H8Cl3NO4S
Acta Crystallographica Section E (2013) 69, 6 o832
a=9.0164(3)Å b=18.6017(5)Å c=9.8574(3)Å
α=90.00° β=111.653(3)° γ=90.00°
<i>N</i>,<i>N</i>,<i>N</i>',<i>N</i>'-Tetramethylethylenediammonium tetrachloridozincate
C6H18N22,ZnCl42
Acta Crystallographica Section E (2013) 69, 12 m642
a=6.893(4)Å b=8.257(6)Å c=13.330(10)Å
α=72.78(3)° β=87.44(3)° γ=69.42(3)°